Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 Trial.
Fumet JD, Lardenois E, Ray-Coquard I, Harter P, Joly F, Canzler U, Truntzer C, Tredan O, Liebrich C, Lortholary A, Pissaloux D, Leary A, Pfisterer J, Eeckhoutte A, Hilpert F, Fabbro M, Caux C, Alexandre J, Houlier A, Sehouli J, Sohier E, Kimmig R, Dubois B, Spaeth D, Treilleux I, Frenel JS, Herwig U, Le Saux O, Bendriss-Vermare N, du Bois A. Fumet JD, et al. Cancers (Basel). 2022 Feb 25;14(5):1189. doi: 10.3390/cancers14051189. Cancers (Basel). 2022. PMID: 35267497 Free PMC article.
Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment.
Fumet JD, Limagne E, Thibaudin M, Truntzer C, Bertaut A, Rederstorff E, Ghiringhelli F. Fumet JD, et al. BMC Cancer. 2020 Aug 10;20(1):748. doi: 10.1186/s12885-020-07253-x. BMC Cancer. 2020. PMID: 32778095 Free PMC article.
Targeting BRAF and RAS in Colorectal Cancer.
Bellio H, Fumet JD, Ghiringhelli F. Bellio H, et al. Among authors: fumet jd. Cancers (Basel). 2021 May 3;13(9):2201. doi: 10.3390/cancers13092201. Cancers (Basel). 2021. PMID: 34063682 Free PMC article. Review.
Phase I Dose-Escalation Trial of an Innovative Chemotherapy Regimen Combining a Fractionated Dose of Irinotecan Plus Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Folinic Acid (bFOLFIRINOX-3) in Chemorefractory Metastatic Colorectal Cancer.
Bellio H, Bertaut A, Hervieu A, Zanetta S, Hennequin A, Vincent J, Palmier R, Bengrine-Lefevre L, Ghiringhelli F, Fumet JD. Bellio H, et al. Among authors: fumet jd. Cancers (Basel). 2021 Oct 30;13(21):5472. doi: 10.3390/cancers13215472. Cancers (Basel). 2021. PMID: 34771635 Free PMC article.
44 results